March 13, 2018 / 1:21 PM / 9 months ago

BRIEF-Exalenz Bioscience’s BreathID Hp & BreathID Hp Lab Systems Receive FDA Clearance For Diagnosis Of Helicobacter Pylori Testing In Pediatric Patients

March 13 (Reuters) - Exalenz Bioscience Ltd:

* EXALENZ BIOSCIENCE’S BREATHID® HP & BREATHID HP LAB SYSTEMS RECEIVE FDA CLEARANCE FOR DIAGNOSIS OF HELICOBACTER PYLORI TESTING IN PEDIATRIC PATIENTS

* EXALENZ BIOSCIENCE- U.S. FDA CLEARED BREATHID HP POINT-OF-CARE SYSTEM, BREATHID HP LAB SYSTEM FOR DETECTING H. PYLORI BACTERIA IN AGES 3-17 YEARS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below